20 May 2013
Keywords: pfizer, celsentri, gets, european, commission, approval, patients
Article | 01 October 2007
US drug giant Pfizer says that the European Commission has approved its drug Celsentri (maraviroc) for treatment experienced HIV patients.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2007
© 2013 thepharmaletter.com